KoBioLabs, Inc (KOSDAQ:348150)
South Korea
· Delayed Price · Currency is KRW 5,240.00
+180.00 (3.56%)
At close: Jul 11, 2025, 3:30 PM KST
KoBioLabs Revenue
KoBioLabs had revenue of 17.30B KRW in the quarter ending March 31, 2025, with 16.02% growth. This brings the company's revenue in the last twelve months to 70.75B, up 75.33% year-over-year. In the year 2024, KoBioLabs had annual revenue of 68.36B with 106.28% growth.
Revenue (ttm)
70.75B
Revenue Growth
+75.33%
P/S Ratio
1.44
Revenue / Employee
n/a
Employees
n/a
Market Cap
101.75B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| Samsung Biologics | 4,898.69B |
| LG Energy Solution | 25.76T |
| Hyundai Motor Company | 178.98T |
| KB Financial Group | 14.93T |
| Doosan Enerbility | 15.88T |
| Celltrion | 3,662.23B |